[Federal Register Volume 74, Number 122 (Friday, June 26, 2009)]
[Notices]
[Page 30592]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: E9-15067]


-----------------------------------------------------------------------

DEPARTMENT OF HEALTH AND HUMAN SERVICES

National Institutes of Health


National Cancer Institute; Notice of Closed Meetings

    Pursuant to section 10(d) of the Federal Advisory Committee Act, as 
amended (5 U.S.C. App.), notice is hereby given of the following 
meetings.
    The meetings will be closed to the public in accordance with the 
provisions set forth in sections 552b(c)(4) and 552b(c)(6), Title 5 
U.S.C., as amended. The grant applications and the discussions could 
disclose confidential trade secrets or commercial property such as 
patentable material, and personal information concerning individuals 
associated with the grant applications, the disclosure of which would 
constitute a clearly unwarranted invasion of personal privacy.

    Name of Committee: National Cancer Institute Special Emphasis 
Panel. NCI ARRA Grand Opportunities Cancer Vaccines.
    Date: August 5-6, 2009.
    Time: 8 a.m. to 5 p.m.
    Agenda: To review and evaluate grant applications.
    Place: Marriott Bethesda North Hotel & Conf. Ctr., Bethesda, MD.
    Contact Person: Shamala K. Srinivas, PhD, Scientific Review 
Officer, Research Programs Review Branch, Division of Extramural 
Activities, National Cancer Institute, 6116 Executive Boulevard, 
Room 8123, Bethesda, MD 20892. 301-594-1224. <a href="/cdn-cgi/l/email-protection#40333375737734002e29286e272f36"><span class="__cf_email__" data-cfemail="c4b7b7f1f7f3b084aaadaceaa3abb2">[email protected]</span></a>.

    Name of Committee: National Cancer Institute Special Emphasis 
Panel. NCI-ARRA Grand Opportunities--Stem Cells.
    Date: August 5-6, 2009.
    Time: 8 a.m. to 5 p.m.
    Agenda: To review and evaluate grant applications.
    Place: Marriott Bethesda North Hotel and Conf. Ctr., Bethesda, 
MD.
    Contact Person: Shakeel Ahmad, PhD, Scientific Review Officer, 
Research Programs Review Branch, Division of Extramural Activities, 
National Cancer Institute, NIH, 6116 Executive Boulevard, Room 8139, 
Bethesda, MD 20892-8328. (301) 594-0114. <a href="/cdn-cgi/l/email-protection#bddcd5d0dcd9cefdd0dcd4d193d3d4d593dad2cb"><span class="__cf_email__" data-cfemail="15747d787471665578747c793b7b7c7d3b727a63">[email protected]</span></a>.

    Name of Committee: National Cancer Institute Special Emphasis 
Panel. NCI ARRA Grand Opportunities--Transcriptional & 
Translational.
    Date: August 5-6, 2009.
    Time: 8 a.m. to 5 p.m.
    Agenda: To review and evaluate grant applications.
    Place: Marriott Bethesda North Hotel and Conf. Ctr., Bethesda, 
MD.
    Contact Person: Thomas M Vollberg, PhD, Scientific Review 
Officer, Special Review and Logistics Branch, Division of Extramural 
Activities, National Cancer Institute, 6116 Executive Boulevard, 
Room 7142, Bethesda, MD 20892. 301-594-9582. <a href="/cdn-cgi/l/email-protection#04726b6868666176704469656d682a6a6d6c2a636b72"><span class="__cf_email__" data-cfemail="45332a2929272037310528242c296b2b2c2d6b222a33">[email protected]</span></a>.

    Name of Committee: National Cancer Institute Special Emphasis 
Panel. NCI ARRA Grand Opportunities-Molecular Targets & Cancer 
Genomics.
    Date: August 5-6, 2009.
    Time: 8 a.m. to 5 p.m.
    Agenda: To review and evaluate grant applications.
    Place: Marriott Bethesda North Hotel and Conf. Ctr., Bethesda, 
MD.
    Contact Person: Adriana Stoica, PhD, Scientific Review Officer, 
Special Review & Logistics Branch, Division of Extramural 
Activities, National Cancer Insitute, NIH, 6116 Executive Blvd, Ste 
703, Rm 7072, Bethesda, MD 20892-8329. 301-594-1408. 
<a href="/cdn-cgi/l/email-protection#d083a4bfb9b3b1b1e290bdb1b9bcfebeb9b8feb7bfa6"><span class="__cf_email__" data-cfemail="6437100b0d070505562409050d084a0a0d0c4a030b12">[email protected]</span></a>.

(Catalogue of Federal Domestic Assistance Program Nos. 93.392, 
Cancer Construction; 93.393, Cancer Cause and Prevention Research; 
93.394, Cancer Detection and Diagnosis Research; 93.395, Cancer 
Treatment Research; 93.396, Cancer Biology Research; 93.397, Cancer 
Centers Support; 93.398, Cancer Research Manpower; 93.399, Cancer 
Control; 93.701, ARRA Related Biomedical Research and Research 
Support Awards, National Institutes of Health, HHS)

    Dated: June 19, 2009.
Jennifer Spaeth,
Director, Office of Federal Advisory Committee Policy.
[FR Doc. E9-15067 Filed 6-25-09; 8:45 am]
BILLING CODE 4140-01-P


</pre><script data-cfasync="false" src="/cdn-cgi/scripts/5c5dd728/cloudflare-static/email-decode.min.js"></script></body>
</html>